Minimal sex-differential modulation of reactivity to pathogens and toll-like receptor ligands following infant Bacillus Calmette–Guérin Russia vaccination

Minimal sex-differential modulation of reactivity to pathogens and toll-like receptor ligands following infant Bacillus Calmette–Guérin Russia vaccination

Bacillus Calmette–Guérin (BCG), the only licensed vaccine against tuberculosis, has been shown to provide heterologous protection against unrelated pathogens and enhance antibody responses to several routine expanded program on immunization (EPI) vaccines. Understanding these heterologous effects is...

Descripció completa

Dades bibliogràfiques
Autors principals:	Darboe, F, Adetifa, JU, Reynolds, J, Hossin, S, Plebanski, M, Netea, MG, Rowland-Jones, SL, Sutherland, JS, Flanagan, KL
Format:	Journal article
Publicat:	Frontiers Media 2017

Ítems similars

Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette–Guérin Russia Vaccination
per: Fatoumatta Darboe, et al.
Publicat: (2017-09-01)

Reiter's syndrome postintravesical Bacillus Calmette–Guérin instillations
per: Ng, K.L., et al.
Publicat: (2017)

Bacillus Calmette–Guérin Immunotherapy for Cancer
per: Fabíola Cardillo, et al.
Publicat: (2021-05-01)

Bacillus Calmette–Guérin and Bladder Cancer
per: Azad H.A. Razack
Publicat: (2007-10-01)

Hepatitis in Disseminated Bacillus Calmette-Guérin Infection
per: Markus U Göttke, et al.
Publicat: (2000-01-01)

Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
per: Dayoung Ko, et al.
Publicat: (2022-04-01)

Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency
per: Ewa Anna Bernatowska, et al.
Publicat: (2007-05-01)

Breast abscess due to Bacillus Calmette-Guérin
per: Aurélien Dinh, et al.
Publicat: (2017-06-01)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
per: Oluwafolajimi A. Adesanya, et al.
Publicat: (2021-02-01)

Is it time to rethink maintenance Bacillus Calmette-Guerin?
per: Vivek Venkatramani
Publicat: (2012-01-01)

Bacillus Calmette-Guerin in the management of superficial bladder cancer
per: Rakesh Kapoor, et al.
Publicat: (2008-01-01)

Bacillus Calmette–Guérin in Immuno-Regulation of Alzheimer’s Disease
per: Benjamin Y. Klein, et al.
Publicat: (2022-06-01)

The management and outcome of Bacillus Calmette–Guérin vaccine overdose
per: Sung-Hsi Wei, et al.
Publicat: (2018-04-01)

Sternal osteomyelitis after bacillus Calmette-Guérin vaccination
per: Rolandas Selvestravičius, et al.
Publicat: (2016-09-01)

Saudi urologists’ treatment pattern for high-risk Bacillus Calmette–Guérin naïve and Bacillus Calmette–Guérin unresponsive nonmuscle invasive bladder cancer
per: Mohammad Alghafees, et al.
Publicat: (2025-01-01)

Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer
per: Yun Peng, et al.
Publicat: (2024-12-01)

Bacillus calmette–Guérin scar inflammation after COVID vaccination
per: B N Shiva Prasad
Publicat: (2022-01-01)

Granulomatous Prostatitis Associated with Intravesical Bacillus Calmette Guerin Therapy
per: Elif Gündoğdu
Publicat: (2024-02-01)

Childhood lupus vulgaris after Bacillus Calmette–Guérin vaccine
per: Sarah Hamdy Soliman, et al.
Publicat: (2023-01-01)

Intravescical instillation of Calmette-Guérin bacillus and COVID-19 risk
per: Ugo Fedeli, et al.
Publicat: (2021-02-01)

Effects of Bacillus Calmette-Guérin on immunometabolism, microbiome and liver diseases
per: Muhammad Umair Ijaz, et al.
Publicat: (2023-06-01)

Newly sequenced genomes of four Bacillus Calmette Guerin vaccines
per: Maria Carolina Sisco, et al.
Publicat: (2020-05-01)

Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?
per: Renata Monteiro-Maia, et al.
Publicat: (2014-09-01)

The Current Status of Bacillus Calmette‐Guérin Vaccine Protective Efficacy
per: Patricia Méndez-Samperio
Publicat: (2019-06-01)

Erythema at the bacillus Calmette-Guerin scar after influenza vaccination
per: Yanin Chavarri-Guerra, et al.
Publicat: (2019-12-01)

Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
per: Suleiman Al-Hammadi, et al.
Publicat: (2017-05-01)

Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
per: Fernando Korkes, et al.
Publicat: (2021-02-01)

Bacillus Calmette-Guérin vaccine-related complications in children in Oman
per: Badria Al Waili, et al.
Publicat: (2021-02-01)

Intravesical Bacillus Calmette-Guerin for Treatment of Refractory Interstitial Cystitis
per: Saeed Arasteh, et al.
Publicat: (2007-02-01)

Bacillus Calmette-Guérin Adenitis: An Intriguing Series of Four Cases
per: Meghadipa Mandal, et al.
Publicat: (2024-01-01)

The impact of Bacillus Calmette-Guérin vaccination on antibody response after COVID-19 vaccination
per: Esther J.M. Taks, et al.
Publicat: (2023-11-01)

The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections
per: Konstantin Föhse, et al.
Publicat: (2023-02-01)

Tuberculous Spondylitis following Intravesical Bacillus Calmette-Guerin for Bladder Cancer
per: Masashi Miyazaki, et al.
Publicat: (2016-01-01)

Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin
per: Sara Feola, et al.
Publicat: (2021-07-01)

Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin
per: Sayed Ab. Reshad Ghafouri, et al.
Publicat: (2018-01-01)

The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
per: Junli Li, et al.
Publicat: (2021-01-01)

Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China
per: Junli Li, et al.
Publicat: (2022-07-01)

Lectinhistochemical staining of granuloma induced by bacillus Calmette-Guerin in Piaractus mesopotamicus
per: Wilson G. Manrique, et al.
Publicat: (2013-11-01)

Endovascular repair of a bacillus Calmette-Guérin mycotic aortic aneurysm
per: Nader Tehrani, MD, et al.
Publicat: (2022-12-01)

Use of the Human Vaccine, Mycobacterium bovis Bacillus Calmette Guérin in Deer
per: Mitchell V. Palmer, et al.
Publicat: (2018-10-01)